Innovative approaches to collecting, aggregating, and analyzing adverse drug events in smart hospitals
International Journal of Risk & Safety in Medicine · 2025
DOI: 10.1177/09246479251365094 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Risk & Safety in Medicine, 2025. Verfasst von Francesco De Pretis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Data Collection, Drug-Related Side Effects and Adverse Reactions, Electronic Health Records. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instrumentariumin Tiedesäätiö.
Abstract (Originalsprache)
Background
The increasing integration of electronic health records (EHRs) and their secondary use provide new pathways to advance drug safety. Smart hospitals use advanced data collection to enhance pharmacovigilance and better detect adverse drug events (ADEs). Finland’s secondary-use legislation embodies this data-sharing shift.
Objective
This work synthesizes current evidence and proposes strategies to strengthen ADE detection and analysis in smart hospitals by integrating multimodal data sources, including EHRs, sensor data, and the Internet of Medical Things (IoMT), to raise overall drug safety standards.
Methods
We review the Global Trigger Tool (GTT), sensor technologies, and IoMT for ADE detection and outline how these techniques can be combined, offering a more comprehensive approach to monitoring.
Results
Integrating GTT, sensors, and IoMT into a unified system could improve ADE detection and prevention. Combining pharmacovigilance tools with advanced technology can increase the volume and quality of ADE data and supports a preventive focus on patient safety.
Conclusions
The study underscores the importance of the smart-hospital concept and emerging data-collection methods in pharmacovigilance. By adopting a holistic approach to ADE detection and integrating diverse data sources, more robust drug-safety surveillance and patient care can be achieved when coupled with human oversight and regulatory compliance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
- School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
- School of Public Health, Indiana University Bloomington, Bloomington, IN, USA.
- Department of Communication and Economics, University of Modena and Reggio Emilia, Reggio Emilia, Italy.
- Kuopio University Hospital, Kuopio, Finland.
- VTT Technical Research Centre of Finland Ltd, Kuopio, Finland.
ORCID-Profile: Francesco De Pretis, Mark van Gils, Markus Varheenmaa, Miia Tiihonen, Markus M Forsberg
Förderung
- Instrumentariumin Tiedesäätiö
Zitieren
APA
De Pretis, F., van Gils, M., Varheenmaa, M., Tiihonen, M., & Forsberg, M. M. (2025). Innovative approaches to collecting, aggregating, and analyzing adverse drug events in smart hospitals. International Journal of Risk & Safety in Medicine. https://doi.org/10.1177/09246479251365094
Vancouver
De Pretis F, van Gils M, Varheenmaa M, Tiihonen M, Forsberg MM. Innovative approaches to collecting, aggregating, and analyzing adverse drug events in smart hospitals. International Journal of Risk & Safety in Medicine. 2025. doi:10.1177/09246479251365094
BibTeX
@article{DePretis2025,
author = {De Pretis, Francesco and van Gils, Mark and Varheenmaa, Markus and Tiihonen, Miia and Forsberg, Markus M},
title = {Innovative approaches to collecting, aggregating, and analyzing adverse drug events in smart hospitals},
journal = {International Journal of Risk & Safety in Medicine},
year = {2025},
doi = {10.1177/09246479251365094}
}
EUVIMED